Moreover, the authors showed that 2-AG level was increased in oxazolone-induced dermatitis, and that treatment with the CB2-selective antagonist SR144528 attenuated the inflammatory response; thus, they concluded that “CB2 and 2-AG play important stimulative roles in the sensitization, elicitation, and exacerbation of allergic inflammation” [214]. The gene discussed is CNR2; the disease is dermatitis.